Diversify Wealth Management LLC Has $4.97 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Diversify Wealth Management LLC cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 22.1% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 9,481 shares of the healthcare conglomerate's stock after selling 2,685 shares during the quarter. Diversify Wealth Management LLC's holdings in UnitedHealth Group were worth $4,966,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of UNH. Xponance Inc. increased its stake in UnitedHealth Group by 4.1% in the first quarter. Xponance Inc. now owns 151,694 shares of the healthcare conglomerate's stock valued at $79,450,000 after purchasing an additional 5,918 shares during the last quarter. Kesler Norman & Wride LLC increased its stake in UnitedHealth Group by 4.9% in the first quarter. Kesler Norman & Wride LLC now owns 20,160 shares of the healthcare conglomerate's stock valued at $10,561,000 after purchasing an additional 950 shares during the last quarter. Country Club Bank increased its stake in UnitedHealth Group by 64.1% in the first quarter. Country Club Bank now owns 8,416 shares of the healthcare conglomerate's stock valued at $4,343,000 after purchasing an additional 3,287 shares during the last quarter. Croban purchased a new stake in UnitedHealth Group during the first quarter valued at about $818,000. Finally, Joseph Group Capital Management grew its position in UnitedHealth Group by 27.9% during the first quarter. Joseph Group Capital Management now owns 9,477 shares of the healthcare conglomerate's stock valued at $4,964,000 after acquiring an additional 2,069 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of research reports. Argus downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Monday, April 21st. Wall Street Zen lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Truist Financial restated a "buy" rating and set a $360.00 price objective (down previously from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Barclays lowered their price objective on UnitedHealth Group from $350.00 to $337.00 and set an "overweight" rating for the company in a research note on Wednesday. Finally, TD Cowen lowered UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price objective for the company. in a research note on Monday, May 19th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group has an average rating of "Moderate Buy" and a consensus target price of $415.00.

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,533 shares of the stock in a transaction on Wednesday, May 14th. The shares were purchased at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the purchase, the director directly owned 6,033 shares of the company's stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Stephen J. Hemsley bought 86,700 shares of the stock in a transaction on Friday, May 16th. The stock was purchased at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the purchase, the chief executive officer directly owned 679,493 shares of the company's stock, valued at approximately $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired 109,408 shares of company stock valued at $31,607,768 in the last ninety days. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Price Performance

Shares of UNH stock traded up $4.30 during mid-day trading on Friday, hitting $303.81. 9,789,082 shares of the stock traded hands, compared to its average volume of 7,687,343. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The firm has a market cap of $275.60 billion, a price-to-earnings ratio of 12.72, a price-to-earnings-growth ratio of 1.43 and a beta of 0.45. The company's 50-day simple moving average is $316.42 and its 200-day simple moving average is $442.28. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same period last year, the firm earned $6.91 earnings per share. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.91%. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. UnitedHealth Group's payout ratio is presently 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.